A study suggests that spinal muscular atrophy (SMA), a genetic neuromuscular disease in infants and children, results primarily from motor circuit dysfunction, not motor neuron or muscle cell dysfunction, as is commonly thought. In a second study, the researchers identified the molecular pathway in SMA that leads to problems with motor function.
Researchers pinpoint the brain regions and brainwave frequencies associated with sleep-enhanced learning of a sequential finger tapping task.
Researchers identify Neurexin2 as a new target for potential treatment of spinal muscular atrophy.
GABA plays a vital role in controlling the involuntary tics associated with Tourette Syndrome.
A new study reveals a link between brain activation, cardiorespiratory fitness and executive function in older adults.
A new study uncovers molecular changes which may explain why motor neurons, rather than other neurons, are affected by the childhood illness, SMA.
Researchers report insufficient blood supply could contribute to motor neuron loss in SMA.
A new study reports on a neurobiological basis for apathy.
A new study implicates a key cellular mechanism as defective in SMA for the first time, providing a new lead for developing future interventions.
A new drug shows promise for improving outcomes for people with SMA.
Researchers have identified how specific brain areas change over time in patients with Parkinson's disease.
Researchers believe they have discovered a promising new treatment for spinal muscular atrophy, a leading genetic cause of death in children.